The WACC of Helix Biopharma Corp (HBP.TO) is 7.3%.
Range | Selected | |
Cost of equity | 9.30% - 12.60% | 10.95% |
Tax rate | 25.90% - 26.50% | 26.20% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 6.5% - 8.2% | 7.3% |
Category | Low | High |
Long-term bond rate | 3.2% | 3.7% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 1.21 | 1.39 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 9.30% | 12.60% |
Tax rate | 25.90% | 26.50% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 6.5% | 8.2% |
Selected WACC | 7.3% | |